ACE inhibitors and angiotensin II receptor blockers could lead to changes in the expression of the ACE2 receptor through which the SARS-CoV-2 spike protein may bind cells [59,60] and hence could affect the likelihood of developing infection following exposure to SARS-CoV-2. Here, ACE is linked to infection.